A Study to Evaluate Electrical Impedance Myography as an Outcome Measure in Myositis

Overview

About this study

The purpose of this study is to assess Electrical Impedance Myography (EIM) as an outcome measure in patients with Idiiopathic Inflammatory Myopathies (IIM) or Myositis.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Adults, age 18 years and older.
  • Healthy Adults, or Adults with a diagnosis of definite or probable idiopathic inflammatory myopathy based upon criteria proposed by Lundberg et al.                           

Exclusion Criteria: 

  • Known pregnancy.
  • Dialysis.
  • Presence of a neurologic disorder in addition to IIM that may significantly affect muscle strength. 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Jacksonville, Fla.

Mayo Clinic principal investigator

Jaimin Shah, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions